CNSP
CNSP
NASDAQ · Pharmaceuticals

Cns Pharmaceuticals Inc

$5.33
+0.10 (+1.81%)
As of Aug 8, 2:37 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +700.4% upside
Low Target $27.73
Average Target $42.66
High Target $55.88
Current Price $5.33
Current
$5.33
Target
$42.66
$27.73 $42.66 avg $55.88
Scenario Analysis
Bear Case
$27.73
420.3%
Low target
Base Case
$42.66
+700.4%
Avg target
Bull Case
$55.88
+948.4%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$10.59
-49.7% from high
52-Week Low
$1.90
+180.5% from low
Target vs 52W High
$42.66
+302.9% vs high
Next Earnings Report
Aug 12, 2026
3d
until earnings
EPS Est: $-0.24
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%